Clinical and Demographic Profile of Cutaneous Melanoma: Pakistani Perspective.

Muhammad Saaiq, Saad Siddiqui
Author Information
  1. Muhammad Saaiq: Department of Plastic Surgery, National Institute of Rehabilitation Medicine (NIRM), Islamabad, Pakistan.
  2. Saad Siddiqui: Department of Plastic Surgery, National Institute of Rehabilitation Medicine (NIRM), Islamabad, Pakistan.

Abstract

BACKGROUND: Cutaneous melanomas (CMs) account for only a small proportion of skin cancers, however these are responsible for most skin cancer deaths. There has been a consistently increasing trend in their incidence across the globe.
METHODS: This prospective case series study spanned over a period of three years. All patients with histologically confirmed CMs were included.
RESULTS: There were 31 patients including 28 males and 3 females with the mean age of 58.25±11.33 years. The histological subtypes included 13 cases (41.93%) of nodular melanoma (NM), 11 patients (35.5%) of acral lentiginous melanoma (ALM), 3 cases (9.67%) of superficial spreading melanoma (SSM) and lentigo maligna melanoma (LMM) and one case (3.22%) of desmoplastic melanoma. Two patients (6.45%) presented with stage II, whereas 21 patients had (67.74%) stage III melanoma. There were 8 patients (25.80%) with stage IV. Time interval between onset of the lesion and first presentation to hospital ranged from 6 to 17 weeks with a mean of 12.45±3.2 weeks. The overall median survival for patients with stage III and IV was 8.75 months. The overall survival for stage II at one year was 100%.
CONCLUSION: CMs more frequently affected males aged ≥58 years. Feet, face, trunk, hands and scalp were the affected anatomical body parts in decreasing order of frequency. NM and ALM were the more common histological subtypes. Majority of patients presented late and advanced stages of melanoma. Awareness about the sinister course of the disease will ensure early presentation with better treatment outcome.

Keywords

References

  1. Beijing Da Xue Xue Bao Yi Xue Ban. 2004 Oct;36(5):469-72 [PMID: 15489924]
  2. Iran J Med Sci. 2016 Mar;41(2):164-5 [PMID: 26989291]
  3. Mayo Clin Proc. 2007 Mar;82(3):364-80 [PMID: 17352373]
  4. MMWR Morb Mortal Wkly Rep. 2012 May 11;61(18):323-6 [PMID: 22572978]
  5. J Am Acad Dermatol. 2017 Nov;77(5):938-945.e4 [PMID: 28864306]
  6. BMC Cancer. 2013 Aug 06;13:372 [PMID: 23915380]
  7. Pediatrics. 2013 May;131(5):846-54 [PMID: 23589817]
  8. PLoS One. 2016 Nov 18;11(11):e0165591 [PMID: 27861496]
  9. Plast Reconstr Surg. 2011 Mar;127(3):37e-56e [PMID: 21364382]
  10. Chonnam Med J. 2016 Sep;52(3):185-93 [PMID: 27689028]
  11. Br J Cancer. 2008 Sep 23;99 Suppl 1:S47-9 [PMID: 18813258]
  12. Arch Dermatol. 2009 Apr;145(4):427-34 [PMID: 19380664]
  13. J Am Acad Dermatol. 2008 Jun;58(6):1013-20 [PMID: 18485983]
  14. Ann Surg Oncol. 2010 Jun;17(6):1475-7 [PMID: 20300965]
  15. Dermatol Online J. 2009 Feb 15;15(2):3 [PMID: 19336020]
  16. Br J Cancer. 2008 Sep 23;99 Suppl 1:S50-2 [PMID: 18813259]
  17. J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S26-37 [PMID: 22018064]
  18. Cancer Causes Control. 1997 Mar;8(2):246-52 [PMID: 9134249]
  19. J Am Acad Dermatol. 2015 May;72(5):794-800 [PMID: 25769192]
  20. An Bras Dermatol. 2015 Mar-Apr;90(2):185-9 [PMID: 25830987]
  21. JAMA Dermatol. 2013 Nov;149(11):1281-8 [PMID: 24067997]
  22. JAMA Otolaryngol Head Neck Surg. 2019 Oct 3;: [PMID: 31580395]
  23. Arch Intern Med. 2006 Sep 25;166(17):1907-14 [PMID: 17000949]
  24. Arch Dermatol. 2009 Dec;145(12):1369-74 [PMID: 20026844]
  25. PLoS One. 2014 Feb 07;9(2):e88096 [PMID: 24516588]
  26. Cancer Control. 2008 Jul;15(3):248-53 [PMID: 18596677]

Word Cloud

Created with Highcharts 10.0.0patientsmelanomastageCutaneousCMsyears3skincaseincludedmalesmeanhistologicalsubtypescasesNMALMone6presentedIIIII8IVpresentationweeksoverallsurvivalaffectedBACKGROUND:melanomasaccountsmallproportioncancershoweverresponsiblecancerdeathsconsistentlyincreasingtrendincidenceacrossglobeMETHODS:prospectiveseriesstudyspannedperiodthreehistologicallyconfirmedRESULTS:31including28femalesage5825±1133134193%nodular11355%acrallentiginous967%superficialspreadingSSMlentigomalignaLMM22%desmoplasticTwo45%whereas216774%2580%Timeintervalonsetlesionfirsthospitalranged171245±32median75monthsyear100%CONCLUSION:frequentlyaged≥58FeetfacetrunkhandsscalpanatomicalbodypartsdecreasingorderfrequencycommonMajoritylateadvancedstagesAwarenesssinistercoursediseasewillensureearlybettertreatmentoutcomeClinicalDemographicProfileMelanoma:PakistaniPerspectiveCancerMelanomaSkin

Similar Articles

Cited By